Alliancebernstein L.P. Intellia Therapeutics, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 265,318 shares of NTLA stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265,318
Previous 2,193,787
87.91%
Holding current value
$3.23 Million
Previous $45.1 Million
93.14%
% of portfolio
0.0%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$153 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$124 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$117 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$63.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$46.4 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $925M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...